A Peek Into The Market Before The Trading Starts
Pre-open movers US stock futures are mostly flat this morning. Futures for the Dow Jones Industrial Average dropped 4 points to 13,035.00 and S&P 500 index futures fell 1.70 points to 1,398.30. Nasdaq 100 futures declined 0.50 points to 2,760.50.
A Peek Into Global Markets European markets were lower today. The STOXX Europe 600 Index fell 0.19%, London's FTSE 100 Index dropped 0.27%, French CAC 40 Index fell 0.18% and German DAX 30 index declined 0.43%.
Asian markets ended lower, with Japan's Nikkei Stock Average declining 1.17%, China's Shanghai Composite falling 0.99% and Australia's S&P/ASX 200 dropping 0.80%. Hong Kong's Hang Seng Index declined 1.25% and India's Sensex fell 0.38%.
Broker Recommendation Analysts at JP Morgan downgraded Autodesk (NASDAQ: ADSK) from “overweight” to “neutral.” The target price for Autodesk has been lowered from $43 to $32.50.
Autodesk shares dropped 21.31% to $28.10 in after-hours trading.
- Ceradyne (NASDAQ: CRDN) announced that ESK Ceramics GmbH & Co. KG, a wholly owned subsidiary based in Kempten, Germany, has entered into a cooperative agreement with Interwell, headquartered in Stavanger, Norway, to market PetroCeram® sand screens and protective sleeves to producers of crude oil and natural gas. To read the full news, click here.
- American Electric Technologies (NASDAQ: AETI) today announced that Frances Powell Hawes, AETI's Chief Financial Officer, has resigned from the Company to pursue other opportunities. To read the full news, click here.
- Eli Lilly and Company (NYSE: LLY) today announced that the primary endpoints, both cognitive and functional, were not met in either of the two Phase 3, double-blind, placebo-controlled solanezumab EXPEDITION trials in patients with mild-to-moderate Alzheimer's disease. To read the full news, click here.
- Tornier NV (NASDAQ: TRNX) today announced that it has signed a definitive agreement to acquire OrthoHelix Surgical Designs, Inc. for $135 million plus additional payments over two years, which will be based on achieving certain revenue growth milestones. To read the full news, click here.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.